StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a research note issued to investors on Saturday. The brokerage issued a sell rating on the basic materials company’s stock.
Arcadia Biosciences Stock Performance
Shares of RKDA stock opened at $5.01 on Friday. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $10.31. The business’s fifty day moving average is $4.81 and its 200-day moving average is $3.70. The stock has a market cap of $6.84 million, a PE ratio of -1.17 and a beta of 0.90.
About Arcadia Biosciences
Recommended Stories
- Five stocks we like better than Arcadia Biosciences
- What is a buyback in stocks? A comprehensive guide for investors
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- How to Buy Cheap Stocks Step by Step
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.